Delayed‐release mesalamine (3 ‐ 4.5 g/day) vs corticosteroids
Induction of remission (CDAI < or =150 with or without decrease of at least 60 points) · patients with Induction of remission or response in Crohn's disease
Delayed‐release mesalamine (3 ‐ 4.5 g/day) showed no clear difference in induction of remission (CDAI < or =150 with or without decrease of… compared with corticosteroids (low certainty).
1 finding from 1 review
- Aminosalicylates for induction of remission or response in Crohn's disease 2016 · Cochrane Headline outcomes onlyRR 0.67 [0.3, 1.46]1 study · 34 participantsLow